How might Veeva evolve its Safety.AI solution to better predict and prevent adverse events in clinical trials?

Introduction

To evolve Veeva's Safety.AI solution for better prediction and prevention of adverse events in clinical trials, we need to analyze the current product, identify key pain points, and propose innovative solutions. I'll approach this by examining user segments, analyzing pain points, generating solutions, and prioritizing improvements based on impact and feasibility.

Step 1

Clarifying Questions

• Looking at Safety.AI's position in the clinical trial ecosystem, I'm curious about its current integration with other Veeva products. Could you share how deeply Safety.AI is integrated with Veeva's Clinical Suite or other offerings?

Why it matters: Determines the scope of potential improvements and data sources available. Expected answer: Moderate integration with some data sharing capabilities. Impact on approach: Would focus on deepening integrations for more comprehensive adverse event prediction.

• Considering the critical nature of adverse event prediction, I'm wondering about the current accuracy rates of Safety.AI. What are the false positive and false negative rates for adverse event predictions?

Why it matters: Helps identify whether to focus on improving sensitivity or specificity. Expected answer: 85% accuracy with a higher false positive rate. Impact on approach: Would prioritize reducing false positives to increase user trust.

• Given the rapid advancements in AI and machine learning, I'm interested in the current AI models used by Safety.AI. What types of AI/ML models are currently employed, and how frequently are they updated?

Why it matters: Informs the potential for incorporating more advanced AI techniques. Expected answer: Using primarily supervised learning models with quarterly updates. Impact on approach: Would explore integrating more advanced models like deep learning or federated learning.

• Considering the global nature of clinical trials, I'm curious about the regulatory landscape. How does Safety.AI currently address different regulatory requirements across various regions?

Why it matters: Ensures proposed solutions are globally applicable and compliant. Expected answer: Built-in compliance for major markets, with some manual adjustments needed. Impact on approach: Would focus on creating a more flexible, adaptive regulatory compliance system.